US Stem Cell Inc (USRM)

[Nano1]

SUNRISE, FL / ACCESSWIRE / March 17, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB:BHRT), an emerging enterprise in the regenerative medicine / cellular therapy industry is pleased to announce, following the release of its Form 10-K Annual Report, key 2014 accomplishments including but not limited to:

2. A 28% decrease in year over year net loss to ($2.25) million in 2014 from ($3.14) million in 2013.